SUBSCRIBE
SUBSCRIBE
News   Policy

FDA Declines to Approve King Pharmaceuticals®, Inc.'s Heart Imaging Drug

October 21, 2009 | 
1 min read

Bookmark and Share

Oct 21 (Reuters) - King Pharmaceuticals Inc (KG.N) said U.S. health regulators declined to approve its heart imaging agent, CorVue injection.

Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Approvals
Ionis’ Tryngolza Becomes First FDA-Approved Therapy for Familial Chylomicronemia Syndrome
December 20, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: 3D illustration of stem cells used for cell therapy
Cell therapy
Mesoblast Wins First Mesenchymal Stromal Cell Therapy FDA Approval for GVHD
December 19, 2024
 · 
2 min read
 · 
Tristan Manalac
Businessman makes employee cuts as part of layoff
Layoffs
The 5 Largest Biopharma Layoffs of 2024
December 19, 2024
 · 
7 min read
 · 
Angela Gabriel
Facade of Novo Nordisk's office in Fremont, California
GLP-1
EMA to Investigate Eye Risk for Novo’s Ozempic: Reuters
December 18, 2024
 · 
2 min read
 · 
Annalee Armstrong